Molecure S.A. (MOC.WA) — Stock Score Summary

Molecure S.A. (MOC.WA) has a MoatMap StockRank of 11/100 based on Quality (26/100), Value (41/100), and Momentum (27/100) factor scores. The current signal is STRONG SELL. Early-stage drug discovery company with binary clinical trial risks and no steady-state owner earnings, failing our fundamental quality and margin of safety requirements.

Molecure S.A. is a clinical-stage biotechnology company focused on discovering and developing small-molecule drugs targeting oncology and inflammatory diseases. The company utilizes a capital-efficient discovery platform targeting chitinases and RNA-mediating proteins, with its lead asset (OATD-01) in clinical trials. Molecure's business model centers on early-to-mid-stage drug discovery, aiming to secure high-value licensing agreements with global pharmaceutical companies.

Key Financial Metrics

Price$1.50
Market Cap$32M
Price/Book1.43
Return on Equity-16.3%
Return on Invested Capital-28.8%
Debt/Equity6.24
Gross Margin-254.0%
Operating Margin-61.3%
Revenue Growth29.0%

Molecure S.A. operates in the Biotechnology industry, part of the Healthcare sector (Poland).

Frequently Asked Questions

What is Molecure S.A.’s (MOC.WA) StockRank?
MoatMap’s StockRank for Molecure S.A. (MOC.WA) is 11/100, with a Strong Sell signal. It is a composite of Quality (26), Value (41), and Momentum (27) factor ranks across MoatMap’s 19,000+ stock universe.
Does Molecure S.A. have an economic moat?
Molecure S.A. (MOC.WA) has a Quality factor score of 26/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Molecure S.A. a buy, hold, or sell?
MoatMap’s current signal for Molecure S.A. (MOC.WA) is Strong Sell, based on a StockRank of 11/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Molecure S.A. in?
Molecure S.A. (MOC.WA) operates in the Healthcare sector, specifically the Biotechnology industry (Poland).
Browse all ranked stocksMOC.WA deep dive reportAI ChampionsHow we score stocksSense-check another stock